David Reardon

David Reardon

Company: Dana-Farber Cancer Institute

Job title: Clinical Director & Professor of Medicine


Optimising Clinical Outcomes in GBM: Overcoming the Tumor Microenvironment & Optimising Biomarkers & Endpoints for Success 2:15 pm

Discover expert-led insights to overcome GBM barriers like the immunosupressive tumor microenvironment and streamline the integration of novel therapies into clinical trials with an integration of the latest scientific insights into the TME and how we can use novel biomarkers & clinical endpoints to see successful translation of results into clinical trials. This workshop will…Read more

day: Pre-Conference Workshop Day New

Glioblastoma Clinical Trials: Optimizing Biomarkers, Endpoints, & Models for Success 2:05 pm

Gain practical insights on how to integrate novel technology into GBM clinical trials. This workshop will gather experts to discuss: Maximizing clinical trial efficiency with advanced biomarkers. Leveraging cutting-edge biomarker technologies, including liquid biopsy, for patient stratification and enhancing early detection of treatment response and progression with dynamic biomarkers. Defining robust endpoints for precise treatment…Read more

day: Workshop Track 2 Post-Lunch

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.